DS7300-188

Name: DS7300-188
Author: Medable Inc.

Medable Inc.

⬇ 50+ downloads

Est. actual: 59

Free

Released: Apr 22, 2024

No in-app purchases

No ads

Rated: Everyone

Signals

3 this week · 3 positive All of this week's signals →

📈Last 7 days 0 installs · 0/day since Sep 29
🏆Among Medical apps bottom 0% by installs gained this week (120 peers growing)
🛠Updates actively updated · updated 9 days ago · every ~832 days (2 updates tracked)

Installs since launch

+1 installs since Sep 29

Update history

5.5.901.1-prod Nov 3, 2026 · seen Nov 11, 2026

Bug fixes

5.5.700.5-prod Jul 23, 2024 · seen Sep 29, 2026

Bug fixes

DS7300-188 is a medical app by Medable Inc. with 50+ downloads (about 59 estimated). Released Apr 22, 2024. Install growth, rank history, SDKs and ad networks.

From the store listing: “A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.”